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Invasive electrophysiology has substantially advanced over previous years. Procedures such 
as defibrillator implantations or pulmonary vein isolation that have previously been an 
exclusive domain of major centers are presently available from many small clinics. This 
somewhat contrasts with general perception of noninvasive electrophysiology. Whilst 
substantial noninvasive research advances have been reported, their wide utility in clinical 
practice is not forthcoming. Some teaching centers even believe that noninvasive 
electrophysiology including electrocardiography is not worth teaching and that standard 
electrocardiographic diagnoses can rely on computerized diagnoses by modern equipment. 
At the same time, existing research suggests that noninvasive electrophysiology can address 
a wide spectrum of unmet clinical needs. In addition to the distinction between patients 
benefitting and not benefiting from defibrillator implantation[1] and diagnosis of 
channelopathies[2], advanced electrocardiography was reported to aid stratification of 
patients with both cardiovascular and non-cardiovascular diagnoses, including kidney 
disease[3], diabetes[4], endocrinopathies[5], and others[6]. 
In this issue of the Journal, Yodogawaetal[7] add another piece to this mosaic showing 
possible advantages offered by high-resolution electrocardiography to early diagnosis of 
cardiac sarcoidosis. Using simple assessment of late potentials previously designed to detect 
large proarrhythmic ischemic scars, they predicted the risk of sarcoidosis-related 
cardiovascular events, albeit merging rhythm disturbances and hemodynamic dysfunction. 
The mechanistic link between positive late potentials and the nature of events described by 
Yodogawaetal is not easy to see. The finding thus likely means nonspecific identification of 
cardiac sarcoidosis which might cause variety of abnormalities. Regretfully, Yodogawaetal 
have also not employed any of the more advanced methods for the signal analysis reported 
to detect not only late depolarization abnormalities but also deformities well within the QRS 
complex [8,9]. We can only speculate that if these more powerful methods were used, the 
success reported by Yodogawa et al would have been stronger. Still, even with the simpler 
signal analyses, the report broadens the applicability of noninvasive methods.  
Naturally, not all previous attempts of clinical outcome improvements by noninvasive 
electrophysiology have been successful[10]. Nevertheless, considering the disparity between 
research results and day-to-day clinical application, we share the opinion that noninvasive 
electrophysiology methods do not presently receive due attention in studies that define 
evidence-based care. The simplicity of obtaining high quality digital electrocardiographic 
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signals and their low costs make noninvasive electrophysiology suitable to be included not 
only in large clinical studies but also in new population screening programs. For example, 
evidence suggests that noninvasive electrophysiology can meaningfully contribute to the 
identification of patients in whom sudden cardiac death is the first manifestation of ischemic 
heart disease[11,12,13], as well as to the detection of impending atrial fibrillation[14], which 
are both major challenges of present preventive cardiology.  
To connect the clinical day-to-day practice with reported research results, new large 
prospective investigations are needed. Their successful conduct will depend not only on the 
understanding of the potential of noninvasive methods by funding bodies but also on the 
industrial support and on the acceptance by clinical community. The manufacturers of 
noninvasive equipment should facilitate the collection of high quality electrocardiographic 
signals well above the standard 10-second recordings and the storage of digital signals in 
easily accessible formats. The clinical community involved in future studies should 
appreciate the potential value of high quality signal collection. Far too frequently are 
electrocardiographic recordings obtained in ongoing studies stored only as paper prints 
which precludes their advanced analyses. The designers of future prospective studies can 
only gain from involving specialists in noninvasive electrophysiology.  
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